Case Studies

Two large prospective, multi-institutional clinical studies report excellent clinical outcomes and low toxicity in localized prostate cancer patients. These studies provide robust clinical data supporting the efficacy of the CyberKnife® System in delivering ultra-hypofractionated stereotactic body radiotherapy (SBRT) for patients with low- and intermediate-risk prostate cancer. The following table describes

Established in October 2007, the Huashan Hopsital CyberKnife Center at Fudan University is one of China’s earliest facilities of its kind.

This case study demonstrates the versatility of the CyberKnife® Treatment Delivery System enabling treatment to be delivered to complex and challenging cases.

A 42-year-old male with chronic hepatitis B was initially diagnosed with primary liver cancer. He received radiofrequency ablation. Then an MRI revealed recurrence in front of the original lesion. The patient underwent interventional therapy in March 2012, but was hospitalized a month later when a CT showed a residual tumor

This study provides robust clinical data supporting the efficacy of the CyberKnife System for trigeminal neuralgia. CyberKnife frameless radiosurgery offers a precise, non-invasive technique with clinical outcomes comparable to Gamma Knife frame-based radiosurgery.